Thursday, January 28, 2016 5:17:00 AM PDT | VentureDeal
Langhorne, Pennsylvania -- Aprecia Pharmaceuticals has announced the close of a $35 million round of venture capital funding.
Aprecia has developed a proprietary three-dimensional printing technology platform optimized for high-dose medications. Called ZipDose, the technology enables higher doses to be taken orally by patients. Deerfield Capital led the round which also included JW Asset Management. Along with the financing, all of the company's outstanding convertible debt was converted into preferred stock.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
